Summit Global Investments Ironwood Pharmaceuticals Inc Transaction History

Summit Global Investments

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	BUY	$8.25 - $11.35 $105,476 - $145,109	12,785 Added 62.55%	33,225 $320,000
Q2 2023 Jul 18, 2023	BUY	$10.1 - $11.6 $72,114 - $82,824	7,140 Added 53.68%	20,440 $217,000
Q4 2022 Jan 31, 2023	BUY	$9.9 - $12.43 $2,970 - $3,729	300 Added 2.31%	13,300 $165,000
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $131,820 - $160,940	13,000 New	13,000 $135,000
Q1 2022 Apr 29, 2022	SELL	$10.61 - $12.88 $442,882 - $537,636	-41,742 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $388,788 - $499,410	-35,800 Reduced 46.17%	41,742 $487,000
Q3 2021 Nov 08, 2021	BUY	$11.92 - $13.92 $116,816 - $136,416	9,800 Added 14.47%	77,542 $1.01 Million
Q2 2021 Jan 28, 2022	SELL	$10.16 - $13.11 $33,528 - $43,263	-3,300 Reduced 4.65%	67,742 $872,000
Q1 2021 Jan 27, 2022	BUY	$9.04 - $11.86 $642,219 - $842,558	71,042 New	71,042 $794,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.